Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of daridorexant in pediatric insomnia disorder
2021-003867-87Phase 2Terminated
- Sponsor
- Idorsia
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing Daridorexant with Placebo (2 arms). Primary endpoint: Change from baseline to Day 1 in total sleep time by PSG. Started Jul 2022; status: terminated.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2021-003867-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003867-87.